ArticleFrontiers in pharmacology2025

The Rho/MRTF-pirin axis: a promising target for overcoming melanoma drug resistance.

Xiaoyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.